344 Participants Needed

Dietary Intervention for Bladder Cancer

KY
Overseen ByKaren Yeary, MD
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: Roswell Park Cancer Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. However, it does exclude participants who had chemotherapy or radiotherapy within 4-6 weeks before the study, so it's best to discuss your specific medications with the trial coordinators.

What data supports the effectiveness of the treatment Cruciferous Vegetable Eating Program for bladder cancer?

Research suggests that eating cruciferous vegetables, which contain compounds called isothiocyanates, may help reduce the risk of bladder cancer and improve survival rates. Studies have shown that these vegetables can have protective effects against bladder cancer, especially when consumed raw.12345

Is the Cruciferous Vegetable Eating Program safe for humans?

Research suggests that increasing intake of cruciferous vegetables, like broccoli, is generally safe for humans and may even help reduce the risk of bladder cancer. These vegetables contain compounds that have been studied for their potential health benefits, and no significant safety concerns have been reported in the studies reviewed.13456

How does the Cruciferous Vegetable Eating Program treatment differ from other bladder cancer treatments?

The Cruciferous Vegetable Eating Program is unique because it uses a dietary approach to increase the intake of cruciferous vegetables, which contain isothiocyanates that may help prevent bladder cancer recurrence and progression. Unlike traditional treatments, this program is noninvasive, cost-effective, and focuses on the chemoprotective properties of natural food components.12457

What is the purpose of this trial?

This phase II trial is being done to develop and test a healthy eating program to reduce cancer recurrence (cancer that has come back after a period of improvement) and/or progression (cancer that is growing, spreading, or getting worse) in patients with non-muscle invasive bladder cancer (NMIBC). Researchers want to better understand how incorporating more cruciferous vegetables in the diet may reduce the risk of cancer recurrence or progression in men and women who were diagnosed with early-stage bladder cancer and compare whether extending the program can further improve bladder cancer outcomes. POW-R Health is a behavioral dietary intervention designed to modestly increase cruciferous vegetable (cruciferae) intake in patients. Cruciferous vegetables, such as cabbage, kale and broccoli, arugula, contain phytochemicals known as isothiocyanates (ITCs). Dietary ITCs exert potent anticancer activities against bladder cancer and can be rapidly metabolized, delivered to the bladder, and concentrated in the urine. Participating in the healthy eating program may reduce bladder cancer recurrence or progression in NMIBC survivors.

Eligibility Criteria

This trial is for men and women diagnosed with non-muscle invasive bladder cancer (NMIBC) who are interested in a dietary program to potentially reduce the risk of their cancer coming back or getting worse. Specific eligibility criteria details were not provided.

Inclusion Criteria

Cancer not reported by a lab, nursing home, or death certificate/autopsy only
I have not had surgery to remove my bladder.
English speaking
See 3 more

Exclusion Criteria

Unwilling or unable to follow protocol requirements
I do not have any severe illnesses or social situations that would stop me from following the study's requirements.
I am not pregnant, imprisoned, or have cognitive impairments affecting my decision-making.
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in the POW-R Health intervention to increase cruciferous vegetable intake

24 months
Regular phone calls and study material distribution

Follow-up

Participants are monitored for urinary isothiocyanates (ITCs) levels and cruciferae intake

4 weeks

Treatment Details

Interventions

  • Cruciferous Vegetable Eating Program
Trial Overview The study tests a healthy eating program called POW-R Health, focusing on increasing intake of cruciferous vegetables like cabbage, kale, broccoli, and arugula to see if they can help prevent bladder cancer from returning or progressing.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Arm II - POW-R Health Only/Core + MaintenanceExperimental Treatment1 Intervention
Patients receive study materials and phone calls during life of study
Group II: AdaptationExperimental Treatment1 Intervention
CAB members participate in maintenance phase development discussion over an hour up to 3 times per week.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Roswell Park Cancer Institute

Lead Sponsor

Trials
427
Recruited
40,500+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

References

A randomized pilot trial of dietary modification for the chemoprevention of noninvasive bladder cancer: the dietary intervention in bladder cancer study. [2021]
Intake of cruciferous vegetables modifies bladder cancer survival. [2022]
Consumption of cruciferous vegetables and the risk of bladder cancer in a prospective US cohort: data from the NIH-AARP diet and health study. [2021]
Cruciferous Vegetable Intervention to Reduce the Risk of Cancer Recurrence in Non-Muscle-Invasive Bladder Cancer Survivors: Development Using a Systematic Process. [2022]
Consumption of raw cruciferous vegetables is inversely associated with bladder cancer risk. [2021]
Cruciferous Vegetables, Isothiocyanates, and Bladder Cancer Prevention. [2021]
Mechanistic review of sulforaphane as a chemoprotective agent in bladder cancer. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity